Related Experiment Videos
Subtotal splenectomy for the treatment of chronic lymphocytic leukemia
1Department of Surgery, Medical School of the Federal University of Minas Gerais, Avenida Alfredo Balena 190, MG 30130-100 Belo Horizonte, Brazil. petroian@medicina.ufmg.br
Insights
Subtotal splenectomy offers a less risky alternative to spleen removal for chronic lymphocytic leukemia (CLL) patients. This conservative approach may achieve similar therapeutic effects with reduced sepsis risk in managing CLL.
Area of Science:
- Oncology
- Hematology
Background:
- Splenectomy is a treatment option for chronic lymphocytic leukemia (CLL), but carries significant risks of sepsis, morbidity, and mortality.
- A conservative approach reducing spleen size, rather than total ablation, may offer similar benefits with lower risks.
Observation:
- An 81-year-old patient with CLL experienced uncontrolled leukemic activity and severe abdominal discomfort due to an enlarged spleen.
- The patient underwent a subtotal splenectomy, a procedure involving partial removal of the spleen.
Findings:
- The subtotal splenectomy resulted in positive outcomes for the patient.
- This suggests that reducing spleen size can be an effective strategy in managing CLL.
Implications:
- Subtotal splenectomy may represent a novel, safer alternative to traditional splenectomy for select CLL patients.
- This procedure could potentially mitigate the high sepsis-related risks associated with full spleen removal in CLL management.
Abstract:
Although splenectomy is helpful in the management of selected patients with chronic lymphocytic leukemia (CLL), in most cases this procedure is accompanied by a greater morbidity and mortality, mainly due to sepsis. Thus, it may be proposed that a conservative procedure that reduces the spleen size may have an effect similar to that of total spleen ablation for the treatment of CLL. The present paper describes our experience with an 81-year-old patient submitted to subtotal splenectomy for treatment of CLL. Indications for surgery were uncontrolled leukemic activity and intense abdominal discomfort due to the huge spleen. The good results obtained with subtotal splenectomy in the present case indicate that this procedure may be a new alternative for the treatment of CLL when removal of the spleen is indicated.